Gary D Luker, MD
Professor of Radiology
Associate Chair, Department of Radiology
Professor of Biomedical Engineering
Radiology
109 Zina Pitcher Place, BSRB A710
Ann Arbor, MI 48109-2200
[email protected]

Available to mentor

Gary D Luker, MD
Professor
  • About
  • Links
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
  • About

    I am a physician-scientist whose research centers at the interface of cancer biology and molecular imaging. I serve as the Editor of the RSNA journal, Radiology: Imaging Cancer.

    Links
    • Lab website
    Qualifications
    • Research Fellowship
      Washington University in St. Louis School of Medicine, Laboratory of Molecular Radiopharmacology, 2002
    • Fellowship
      Mallinckrodt Institute of Radiology, Pediatric Radiology, 1996
    • Residency
      Washington University in St. Louis School of Medicine, Diagnostic Radiology, 1995
    Center Memberships
    • Center Member
      Rogel Cancer Center
    Research Overview

    The Luker Lab investigates tumor-stromal interactions in cancer that drive tumor growth, metastasis, and drug resistance. The lab applies multi-scale imaging methods to understand tumor heterogeneity and predict early responses to therapy in models ranging from single cells to clinical studies.

    Recent Publications See All Publications
    • Journal Article
      Characterizing heterogeneous single-cell dose responses computationally and experimentally using threshold inhibition surfaces and dose-titration assays.
      Kinnunen PC, Humphries BA, Luker GD, Luker KE, Linderman JJ. NPJ Syst Biol Appl, 2024 Apr 18; 10 (1): 42 DOI:10.1038/s41540-024-00369-x
      PMID: 38637530
    • Journal Article
      Superconducting nanowire single-photon detector enhanced near-infrared II portable confocal microscopy for tissue imaging with indocyanine green
      Liu Y, Yao C-Y, Rambo TM, Li B, Juhong A, Doredla JS, Luker GD, Han M, Miller AJ, Qiu Z. Optics Letters, 2024 Nov 15; 49 (22): 6349 DOI:10.1364/ol.537612
    • Journal Article
      A gravity-driven tissue chip to study the efficacy and toxicity of cancer therapeutics.
      Rafsanjani Nejad P, Lamichhane A, Guragain P, Luker G, Tavana H. Lab Chip, 2024 Nov 1; DOI:10.1039/d4lc00404c
      PMID: 39485368
    • Journal Article
      Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels.
      Sinha S, Callow BW, Farfel AP, Roy S, Chen S, Masotti M, Rajendran S, Buschhaus JM, Espinoza CR, Luker KE, Ghosh P, Luker GD. J Clin Invest, 2024 Oct 31; DOI:10.1172/JCI170953
      PMID: 39480488
    • Preprint
      Inference of weak-form partial differential equations describing migration and proliferation mechanisms in wound healing experiments on cancer cells.
      Kinnunen PC, Srivastava S, Wang Z, Ho KKY, Humphries BA, Chen S, Linderman JJ, Luker GD, Luker KE, Garikipati K. 2024 Oct 24;
      PMID: 39502887
    • Journal Article
      Multihead Attention U-Net for Magnetic Particle Imaging–Computed Tomography Image Segmentation
      Juhong A, Li B, Liu Y, Yang CW, Yao CY, Agnew DW, Lei YL, Luker GD, Bumpers H, Huang X, Piyawattanametha W, Qiu Z. Advanced Intelligent Systems, 2024 Oct 1; 6 (10): DOI:10.1002/aisy.202400007
    • Preprint
      Light-triggered protease-mediated release of actin-bound cargo from synthetic cells.
      Akter M, Moghimianavval H, Luker GD, Liu AP. 2024 Sep 15; DOI:10.1101/2024.09.15.613133
      PMID: 39314483
    • Preprint
      Breast Cancers That Disseminate to Bone Marrow Acquire Aggressive Phenotypes through CX43-related Tumor-Stroma Tunnels.
      Sinha S, Callow BW, Farfel AP, Roy S, Chen S, Rajendran S, Buschhaus JM, Espinoza CR, Luker KE, Ghosh P, Luker GD. 2024 Aug 10; DOI:10.1101/2023.03.18.533175
      PMID: 36993616
    Featured News & Stories bone close up of cells inside green bbble with cells inside in yellow brown pink and red orange background
    Health Lab
    How breast cancer cells survive in bone marrow after remission
    A new study from researchers at the University of Michigan and the University of California San Diego has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells survive in bone marrow despite targeted therapies.